Atezolizumab With Bevacizumab and Nonplatinum Chemotherapy for Recurrent Ovarian Cancer: Final Results From the Placebo-Controlled AGO-OVAR 2.29/ENGOT-ov34 Phase III Trial
Year: 2025
Type: article
Study design: Clinical Trial
Source: Journal of Clinical Oncology
DOI: 10.1200/jco-25-01210
Authors: Philipp Harter, Frederik Marmé, Andrés Redondo, Alexander Reuss, Kristina Lindemann, Christian Kurzeder, Els Van Nieuwenhuysen, Christian Marth, Klaus Pietzner, Isabelle Ray-Coquard, Carmen Garcia-Duran, Goda Jonuskiene, Florian Heitz, Charlotte Béllier, J. Alejandro Pérez-Fidalgo, Ahmed El-Balat, Frédéric Selle, Ignacio Romero, Pauline Wimberger, Philippe Follana, Beatriz Pardo, Nikolaus de Gregorio, Florence Joly, Lydia Gaba, Alexander Burges, Michel Fabbro, Annette Hasenburg, Tanja Fehm, Barbara Schmalfeldt, Patricia Pautier
Institutions: Philipps University of Marburg, Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe, Kliniken Essen-Mitte, Heidelberg University, Medizinische Fakultät Mannheim, Hospital Universitario La Paz, Hospital La Paz Institute for Health Research, Spanish Ovarian Cancer Research Group, Oslo University Hospital, University of Oslo, Nordic Society of Gynecologic Oncology, University Hospital of Basel, Swiss Group For Clinical Cancer Research, Universitair Ziekenhuis Leuven, KU Leuven, Innsbruck Medical University, AGO Austria, Humboldt-Universität zu Berlin, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Charité - Universitätsmedizin Berlin, Centre Léon Bérard, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institute of Oncology, Vilnius University, Vilnius University Hospital Santariskiu Klinikos, Centre Oscar Lambret, Centro de Investigación Biomédica en Red de Cáncer, Goethe University Frankfurt, University Hospital Zurich, University Hospital Frankfurt, Groupe Hospitalier Diaconesses Croix Saint-Simon, Fundación Instituto Valenciano de Oncología, University Hospital Carl Gustav Carus, Nationales Centrum für Tumorerkrankungen Dresden, Technische Universität Dresden, Centre Antoine Lacassagne, Institut Català d'Oncologia, University Hospital Ulm, SLK-Kliniken Heilbronn, Centre François Baclesse, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, LMU Klinikum, Ludwig-Maximilians-Universität München, University Medical Center of the Johannes Gutenberg University Mainz, Düsseldorf University Hospital, University Medical Center Hamburg-Eppendorf, Institut Gustave Roussy
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417035546